Quick Links

Nature News - India takes the lead on tuberculosis innovation

News

Published: 23 Aug 2011

Madhukar Pai has helped to organize the first ever conference to get the Indian pharmaceutical industry interested in TB innovation: 'TB Diagnostics in India: From Importation and Imitation to Innovation', to be held on 25 and 26 August in Bangalore, India.

Madhukar Pai, an epidemiologist and tuberculosis (TB) researcher based at McGill University in Montreal, Canada, is co-chairman of the Stop TB Partnership's New Diagnostics Working Group and a consultant to the Bill & Melinda Gates Foundation, headquartered in Seattle, Washington.

He has helped to organize the first ever conference to get the Indian pharmaceutical industry interested in TB innovation: 'TB Diagnostics in India: From Importation and Imitation to Innovation', to be held on 25 and 26 August in Bangalore, India. Nature caught up with him to find out how he thinks emerging economies, such as India, can help to combat the TB epidemic with improved diagnostics.

Source Site: /newsroom
Classified as: